Delivery Order SPE2DB20D7059-SPE2DB25FPTR0

Award Date 11/4/24
Potential Completion Date 11/26/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $2,064.22, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on May 21, 2025. The contract has an ultimate completion date of June 12, 2025 and is not a set-aside. AmerisourceBergen also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $1,032.11 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 16, 2025 and was awarded on March 26, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award is for the delivery of VARIVAX vaccines with diluents to the Defense Logistics Agency (DLA), a defense agency. The $10,530.10 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 5, 2025, with a completion date of February 27, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on a firm-fixed-price basis for a ceiling value of $94,114.00. The contract has an ultimate completion date of September 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $157,944.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 24, 2025, with a completion date of March 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $18,740.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The $3,096.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 14, 2025. The contract has an ultimate completion date of June 5, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $1,042.56 firm fixed-price delivery order was awarded on May 27, 2025 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 17, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides comprehensive global...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The $19,382.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of December 16, 2024 and was issued on November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $1,977.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024, with a completion date of December 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPTR0
    Delivery Order

This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency. The $2,867.94 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,867.94 and an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/3/25, 1:05 PM